Holen Sie sich die Stockscreener-App
44.98
1.33%
0.59
Handel nachbörslich:
44.98
Schlusskurs vom Vortag:
$44.39
Offen:
$43.99
24-Stunden-Volumen:
2.41M
Relative Volume:
4.18
Marktkapitalisierung:
$2.08B
Einnahmen:
$1.08B
Nettoeinkommen (Verlust:
$-20.76M
KGV:
-58.42
EPS:
-0.77
Netto-Cashflow:
$151.63M
1W Leistung:
-2.24%
1M Leistung:
+7.56%
6M Leistung:
+59.16%
1J Leistung:
+18.59%
1-Tages-Spanne:
$43.49
$45.44
1-Wochen-Bereich:
$43.29
$47.00
52-Wochen-Spanne:
$25.12
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Firmenname
Omnicell Inc
Sektor
Branche
Telefon
(877) 415-9990
Adresse
4220 NORTH FREEWAY, FORT WORTH
Vergleichen Sie OMCL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
44.98 | 2.08B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
224.15 | 36.39B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
66.83 | 11.55B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
57.83 | 10.80B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
94.95 | 8.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.82 | 6.34B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-02 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Eingeleitet | Barclays | Underweight |
| 2023-11-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Bestätigt | Wells Fargo | Underweight |
| 2023-08-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Eingeleitet | BofA Securities | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-12-06 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-09 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-24 | Eingeleitet | BTIG Research | Buy |
| 2021-02-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-12-03 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-02-07 | Bestätigt | Dougherty & Company | Buy |
| 2019-11-21 | Bestätigt | Dougherty & Company | Buy |
| 2019-07-26 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-03-07 | Bestätigt | Dougherty & Company | Buy |
| 2018-06-29 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-09-05 | Bestätigt | The Benchmark Company | Buy |
| 2017-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2017-04-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Eingeleitet | Dougherty & Company | Buy |
| 2016-12-06 | Bestätigt | The Benchmark Company | Buy |
| 2016-07-07 | Bestätigt | FBR Capital | Outperform |
| 2016-03-21 | Bestätigt | Topeka Capital Markets | Buy |
| 2016-01-07 | Eingeleitet | The Benchmark Company | Buy |
| 2015-11-16 | Bestätigt | Topeka Capital Markets | Buy |
| 2015-10-30 | Bestätigt | FBR Capital | Outperform |
| 2015-09-28 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-07-31 | Bestätigt | Topeka Capital Markets | Buy |
Alle ansehen
Omnicell Inc Aktie (OMCL) Neueste Nachrichten
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories - Zacks Investment Research
4 Healthcare Technology Innovators to Invest in Before the New Year - Zacks Investment Research
Why Omnicell (OMCL) Might be Well Poised for a Surge - MSN
Medication Management Market (2024-2032): Industry Insights, - openPR
Omnicell's SWOT analysis: healthcare tech firm's stock faces growth hurdles By Investing.com - Investing.com Canada
Omnicell's SWOT analysis: healthcare tech firm's stock faces growth hurdles - Investing.com India
Don't Ignore The Insider Selling In Omnicell - Simply Wall St
Wellington Management Group LLP Sells 1,148,356 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell director Mark Parrish sells shares worth $567,638 By Investing.com - Investing.com Australia
Omnicell, Inc. (NASDAQ:OMCL) Short Interest Update - MarketBeat
Omnicell partners with Gollmann to expand pharmacy automation solutions - Pharmacy Business
Omnicell director Mark Parrish sells shares worth $567,638 - Investing.com India
Centiva Capital LP Sells 19,341 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 643,292 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Director Mark Parrish Sells 12,000 Shares of Omnicell Inc (OMCL) - GuruFocus.com
What Makes Omnicell (OMCL) a New Strong Buy Stock - MSN
Omnicell Introduces OmniSphere Platform, Stock to Gain - MSN
Future-Proofing Growth of Medication Management - openPR
LSPedia AND OMNICELL COLLABORATE IN AN EFFORT TO ADVANCE PHARMACY SUPPLY CHAIN COMPLIANCE AND INNOVATION FOR HOSPITALS AND HEALTH SYSTEMS - The Eastern Progress Online
Central Fill Pharmacy Automation Market Emerging Trends and Growth Prospects 2032 |Omnicell, McKesson, Swisslog - openPR
Pharmacy Dispensing Automation Market Likely to Boost Future Growth by 2031: McKesson, Omnicell, Cerner - openPR
Omnicell (NASDAQ:OMCL) Lowered to "Hold" Rating by StockNews.com - MarketBeat
Omnicell Announces OmniSphere - Business Wire
Central Fill Pharmacy Automation Market Projected To Witness Substantial Growth, 2024-2031: ARxIUM Inc., - EIN News
Pier Capital LLC Buys New Position in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Healthcare Robotics Market to See Huge Growth by 2030: Stryker Corporation, Omnicell, ARxIUM - openPR
SageView Advisory Group LLC Acquires Shares of 11,019 Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
How To Trade (OMCL) - Stock Traders Daily
Charles Schwab Investment Management Inc. Grows Position in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
The Zacks Analyst Blog Highlights Inspire Medical, Omnicell, Talkspace, Butterfly Network and Clover Health - Barchart
Omnicell Inc (OMCL) Trading Down 3.62% on Dec 3 - GuruFocus.com
Martingale Asset Management L P Invests $507,000 in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Shares Sold by Bridgewater Associates LP - MarketBeat
Rockefeller Capital Management L.P. Acquires 16,116 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Bellevue Group AG Reduces Stake in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Why Is Omnicell (OMCL) Down 0.4% Since Last Earnings Report? - MSN
Omnicell (NASDAQ:OMCL) Stock Price Down 3.7%Time to Sell? - MarketBeat
Dynamic Technology Lab Private Ltd Sells 15,351 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
OMCL (Omnicell) PE Ratio without NRI : 32.58 (As of Nov. 30, 2024) - GuruFocus.com
Algert Global LLC Trims Stake in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Intech Investment Management LLC Makes New Investment in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Should You Investigate Omnicell, Inc. (NASDAQ:OMCL) At US$48.46? - Yahoo Finance
Little Excitement Around Omnicell, Inc.'s (NASDAQ:OMCL) Revenues - Simply Wall St
Millrace Asset Group Inc. Invests $1.22 Million in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Advantage Alpha Capital Partners LP Sells 24,485 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Central Fill Pharmacy Automation Market Future Business - openPR
Omnicell's SWOT analysis: healthcare tech stock navigates market shifts - Investing.com
Omnicell's SWOT analysis: healthcare tech stock navigates market shifts By Investing.com - Investing.com Canada
Global Surgery Management Software Market Size, Share - openPR
Pharmacy Automation System Market to Hit $11.21 Billion by 2030 | Becton, Dickinson and Company, Omnicell, - EIN News
Finanzdaten der Omnicell Inc-Aktie (OMCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.16%
0.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):